The World Health Organization (WHO) has released its first global guidance on managing obesity in children and adolescents, authorizing the use of weight-loss medications and bariatric surgery for youth under specific, strictly defined conditions. These medical interventions should only be considered when comprehensive lifestyle modifications have failed to address severe obesity, according to the new framework.
WHO Global Framework for Pediatric Obesity
The WHO’s new guidelines, as reported by fr.de, provide a standardized approach for governments and health systems to address the rising prevalence of childhood obesity. While the organization previously limited recommendations for weight-loss drugs—such as Wegovy and Mounjaro—and bariatric surgery to adults with a body mass index (BMI) of 30 or higher, this update formally extends the clinical framework to younger populations.
The guidance emphasizes that these clinical interventions are not first-line treatments. They are reserved for cases where structured programs focused on physical activity and nutritional changes have been exhausted.
WHO Sets Age Limits for Weight-Loss Medications and Surgery
The guidelines establish a clear clinical boundary based on age to mitigate potential long-term developmental risks.
- Children aged 10 and older: Medical professionals may consider weight-loss medications or surgical procedures, provided the patient meets strict criteria and has not responded to conservative treatments.
- Children under 10: The WHO explicitly advises against the use of weight-loss medications or surgery, prioritizing lifestyle-based interventions to avoid potential long-term risks.
Despite the availability of pharmacological and surgical options, the WHO maintains that structured lifestyle management remains the primary intervention. For children over five years old, the guidelines recommend a minimum of 60 minutes of moderate-to-vigorous physical activity daily, paired with structured nutritional support.
UNICEF data supports the urgency for these guidelines, estimating that 188 million children and adolescents worldwide are currently living with obesity. Last year marked a historical shift as the number of children affected by obesity surpassed the number of those classified as underweight.
WHO Framework Integrates Psychological Support into Obesity Treatment
The new WHO framework stresses that effective treatment must be holistic.
Clinical care must account for the psychological comorbidities often associated with obesity, including depression, anxiety, and low self-esteem. The guidelines note that these factors can exacerbate unhealthy eating patterns, requiring long-term, integrated support for both the child and their family.
WHO Advises Against Weight-Loss Drugs for Children Under 10
Why are weight-loss drugs not recommended for children under 10? The WHO advises against their use in this age group to prevent potential long-term risks and to prioritize behavioral interventions during critical growth years.
What constitutes the "first line" of treatment for childhood obesity? The WHO mandates that children and adolescents first engage in structured nutrition programs and consistent physical activity, aiming for at least 60 minutes of moderate-to-vigorous movement per day for those over five years old.
Does this guidance mandate that all countries provide these treatments? No. These guidelines serve as a framework for national health authorities to develop their own binding policies and regulatory standards for managing pediatric obesity within their respective healthcare systems.
Keep reading